The use of biomarkers in the patient with heart failure. - Wikidata - awgldk - TriplyDB

The use of biomarkers in the patient with heart failure.

The use of biomarkers in the patient with heart failure.

http://www.wikidata.org/entity/Q38104269

about

Clinical Significance of B-type Natriuretic Peptide in Heart Failure Systematic analysis of blood cell transcriptome in end-stage chronic respiratory diseases.Aberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure.Decreased Peripheral Mitochondrial DNA Copy Number is Associated with the Risk of Heart Failure and Long-term Outcomes.Changes of adrenomedullin and natriuretic peptides in patients with adrenal medullary hyperplasia prior to and following pharmacological therapy and adrenalectomy Prognostic role of copeptin with all-cause mortality after heart failure: a systematic review and meta-analysis.The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failure.The current status of heart failure diagnostic biomarkers.Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure.Optimizing clinical use of biomarkers in high-risk acute heart failure patients.The role of timely measurement of galectin-3, NT-proBNP, cystatin C and hsTnT in predicting prognosis and heart function after heart transplantation.Developing Drugs for Heart Failure With Reduced Ejection Fraction: What Have We Learned From Clinical Trials?Cardiac complications of chemotherapy: role of biomarkers.

P2860

Q27005797-610AC61A-383E-4B6E-9245-421A8844FBE0 Q34373840-231487E7-C2D7-4E77-A8A9-C90A8FA07950 Q36046973-5186BD31-62E5-46A0-B75E-9FEFCFF4FA75 Q36822397-2772FABE-4253-4336-88A0-778903405E17 Q37108587-C9D5525F-61D7-4EA1-AE0E-271AFB4EC9E2 Q37573138-DD780FFF-CBF2-42EF-BEA7-0CFB748E81D3 Q38194209-28FECAD0-F3D9-4289-AEC8-1CE74AF9ADB7 Q38703882-F51EB5B7-AAE9-4E16-879F-79D5026936F0 Q40311889-0CEE710B-5B9E-49E2-BDCC-A9F27BF8F415 Q41074638-F2AB01C9-DF2B-4A9C-A128-63898717D358 Q41385684-72B71136-5158-44EE-9D0B-4B9ECFC1C471 Q48283568-2A6DD394-8C7C-4F7E-8663-A5FAF45D0635 Q51739297-022E4E2D-EAAD-4EC2-9DA0-DBA43A149CF3

P2860

The use of biomarkers in the patient with heart failure.

http://www.wikidata.org/entity/Q38104269

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The use of biomarkers in the patient with heart failure.

@en

type

label

The use of biomarkers in the patient with heart failure.

@en

prefLabel

The use of biomarkers in the patient with heart failure.

@en

P1433

Q38104269-1201F26D-41CF-4174-83E6-3C94F8083835

P1476

Q38104269-F965D9DF-4A48-4BCC-B36E-D5AD5DBBDDDB

P2093

Q38104269-2170E650-90FD-4020-B5D4-3732F9A03F69

Q38104269-69A3733C-DCC2-48BE-9281-A115DAB80FEA

Q38104269-F453FCA1-5FEA-498F-B78C-A8E8231C3FBE

Q38104269-F79E9D94-8D70-41C4-B866-27B8D8A67986

P2860

Q38104269-04C245A1-EF1E-4093-AA36-BEA05EBE66E3

Q38104269-0AB21E0C-05B4-44B5-810E-140826B62E0B

Q38104269-0ABFC758-EB5D-4344-B355-63004F7B93B0

Q38104269-131816B9-2349-4436-8C44-41A5D3103A4E

Q38104269-13F5EA5C-CDFB-4181-9E75-BC301A92ACF7

Q38104269-1B030D28-5034-4664-B5F9-F99C11285F2C

Q38104269-20E0D11E-F6AC-49C3-B344-F6B9431A5BC0

Q38104269-26F6B5DC-B3C7-4880-A700-9AEF3B4849BA

Q38104269-29580B48-EF57-4DF1-B036-5B63E97E515E

Q38104269-2B4A4B9A-B878-4667-A1BF-C15560863833

P2888

Q38104269-7A6AEF79-A076-49D1-9462-17C5F913DB49

P304

Q38104269-93891616-CE19-4F4B-AF86-A1956EE88824

P31

Q38104269-A2BEEC06-8017-4B74-B01D-A3F515DED916

P356

Q38104269-CBC54CAA-8A5D-4A5A-8921-6BB7AEDD9593

P433

Q38104269-1B2E6F95-3A8D-48EE-8802-584A7E28EEC2

P478

Q38104269-C89D147E-42F8-4BFF-BA2E-7E044A1D0F72

P577

Q38104269-47C46226-DA4E-40A4-B968-36C838307D12

P6179

Q38104269-1F791A41-0584-42FB-B43F-F23CA098B8E7

P698

Q38104269-20A2C2DB-E0B0-4E56-BF06-6CE01C244061

P921

Q38104269-0A38EF10-D1B2-45FB-A486-BE9F32412E70

Q38104269-31C3A46F-D12B-4FDE-ABE2-C92D9A9D07AD

Q38104269-68B184E2-0F06-4919-9218-B0E638B75611

P356

S11886-013-0372-4

P1433

Current cardiology reports

P1476

The use of biomarkers in the patient with heart failure.

@en

P2093

Alan Maisel

http://www.w3.org/2001/XMLSchema#string

Devin Kehl

http://www.w3.org/2001/XMLSchema#string

Punam Chowdhury

http://www.w3.org/2001/XMLSchema#string

Rajiv Choudhary

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure

Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study

The role of natriuretic peptide testing in guiding chronic heart failure management: review of available data and recommendations for use

Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial

Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section

Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction

Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction

Interleukin family member ST2 and mortality in acute dyspnoea

P2888

s11886-013-0372-4

P304

372

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11886-013-0372-4

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1023840976

http://www.w3.org/2001/XMLSchema#string

P698

23644993

http://www.w3.org/2001/XMLSchema#string

P921